The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome
Open accessAbstract
BACKGROUND/AIMS: Dysbiosis is associated with various systemic disorders including irritable bowel syndrome (IBS). Fecal microbiota transplantation (FMT) might restore intestinal microbial balance. The study aimed to determine the safety and efficacy of FMT in IBS patients, as well as also positive predictors for FMT. METHODS: This was a single-arm, open-label study. Eligible patients were diagnosed based on Rome III Diagnostic Criteria. Fecal materials were administered to the patient via colonoscopy. The primary end point was a change in the Bristol stool form scale at 4 weeks after FMT. Recovery to types 3-4 was considered a clinical response. The secondary end point was a change in intestinal microbiota and psychological status using the Hamilton Rating Scale. RESULTS: Ten patients were enrolled. Six patients achieved a clinical response. The diversity of patients 4 weeks after FMT increased significantly compared with patients before FMT, and that of responding patients was significantly higher than non-responder patients. The abundance of Bifidobacterium in effective donors was significantly higher than in ineffective donors and patients. Psychological status of all patients was significantly improved after FMT. CONCLUSIONS: FMT for patients with IBS is safe, and relatively effective. Bifidobacterium-rich fecal donor may be a positive predictor for successful FMT. Key Summary: (1) Dysbiosis is associated with various gastrointestinal disorders including IBS. (2) FMT has potential to restore intestinal microbial balance. (3) We showed that FMT improved stool form and psychological status of IBS patients. (4) Bifidobacterium-rich donor efficiently induced symbiosis in IBS patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mizuno et al. [90] in open-label, non-randomized, single-center trials found that psychiatric status of IBS patients, assessed using the Hamilton Rating Scale for Depression (HAMD), was significantly improved at 1 month after FMT from healthy donors, but returned to the baseline level after 12 weeks.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [90]
In the citing paper
“Three of the four studies found a significant improvement in anxiety symptoms following FMT [44, 45, 48].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
In the citing paper
“The long-term effects were less consistent, with three studies finding a return to baseline at week 12, week 20, and month 6 respectively [44–46].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
In the citing paper
“Although Mizuno et al. found improvement in the anxiety scores as well, it was not significant [44].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244
Gut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.046 · Cited by 1,249
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gupta, V. K., Paul, S., & Dutta, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01162 · Cited by 1,019
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 997
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Factors affecting the composition of the gut microbiota, and its modulation
Hasan, N., & Yang, H. (2019) · PeerJ · doi:10.7717/peerj.7502 · Cited by 755
“, 2018), irritable bowel syndrome (Pinn, Aroniadis & Brandt, 2014;Gibson & Roberfroid, 1995; Borody et al., 2004; Holvoet et al., 2017; Mizuno et al., 2017; Aroniadis et al., 2018; Halkjær et al., 2018; Johnsen et al., 2018) constipation (Tian et al.”
BackgroundAn insider's perspective: Bacteroides as a window into the microbiome
Wexler, A. G., & Goodman, A. L. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.26 · Cited by 641
Sex differences in gut microbiota
Kim, Y. S., Unno, T., Kim, B.-Y., & Park, M.-S. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.190009 · Cited by 610
Song, Z., Cai, Y., Lao, X., Wang, X., Lin, X., Cui, Y., Kalavagunta, P. K., Liao, J., Jin, L., Shang, J., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0628-3 · Cited by 505
Epidemiology and risk factors for bipolar disorder
Rowland, T. A., & Marwaha, S. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318769235 · Cited by 503
Hosomi, K., Saito, M., Park, J., Murakami, H., Shibata, N., Ando, M., Nagatake, T., Konishi, K., Ohno, H., Tanisawa, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32015-7 · Cited by 451
Gut microbial carbohydrate metabolism contributes to insulin resistance
Takeuchi, T., Kubota, T., Nakanishi, Y., Tsugawa, H., Suda, W., Kwon, A. T.-J., Yazaki, J., Ikeda, K., Nemoto, S., Mochizuki, Y., et al. (2023) · Nature · doi:10.1038/s41586-023-06466-x · Cited by 438
Self-citationBlautia genus associated with visceral fat accumulation in adults 20–76 years of age
Ozato, N., Saito, S., Yamaguchi, T., Katashima, M., Tokuda, I., Sawada, K., Katsuragi, Y., Kakuta, M., Imoto, S., Ihara, K., et al. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0101-x · Cited by 416
The Super-Donor Phenomenon in Fecal Microbiota Transplantation
Wilson, B. C., Vatanen, T., Cutfield, W. S., & O'Sullivan, J. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00002 · Cited by 413
“To shed light on the varying patient responses to FMT and uncover any donor-dependent effects, a number of studies have carried out microbial profiling on donors and recipients before and after FMT (Vrieze et al., 2012; Moayyedi et al., 2015; Rossen et al., 2015; Vaughn et al., 2016; Vermeire et al., 2016; Bajaj et al…”
BackgroundInfluentialPrecision Nutrition and the Microbiome, Part I: Current State of the Science
Mills, S., Stanton, C., Lane, J., Smith, G., & Ross, R. (2019) · Nutrients · doi:10.3390/nu11040923 · Cited by 399
Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential
Saus, E., Iraola-Guzmán, S., Willis, J. R., Brunet-Vega, A., & Gabaldón, T. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.05.001 · Cited by 350
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic
Porcari, S., Benech, N., Valles-Colomer, M., Segata, N., Gasbarrini, A., Cammarota, G., Sokol, H., & Ianiro, G. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.020 · Cited by 331
Chong, P. P., Chin, V. K., Looi, C. Y., Wong, W. F., Madhavan, P., & Yong, V. C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01136 · Cited by 328
Takagi, T., Naito, Y., Inoue, R., Kashiwagi, S., Uchiyama, K., Mizushima, K., Tsuchiya, S., Dohi, O., Yoshida, N., Kamada, K., et al. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-018-1488-5 · Cited by 314
Microbiome in healthy skin, update for dermatologists
Dréno, B., Araviiskaia, E., Berardesca, E., Gontijo, G., Sanchez Viera, M., Xiang, L. F., Martin, R., & Bieber, T. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13965 · Cited by 292
Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review
Chinna Meyyappan, A., Forth, E., Wallace, C. J. K., & Milev, R. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02654-5 · Cited by 254
“Mizuno 2017 [44] Low High Participants and personnel not blinded.”
BackgroundInfluentialInfluence of Diet and Nutrition on Prostate Cancer
Matsushita, M., Fujita, K., & Nonomura, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041447 · Cited by 223
Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
Song, J. H., & Kim, Y. S. (2019) · Gut and Liver · doi:10.5009/gnl18071 · Cited by 219
Extra-gonadal sites of estrogen biosynthesis and function
Barakat, R., Oakley, O., Kim, H., Jin, J., & Ko, C. J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.9.141 · Cited by 215
Kurokawa, S., Kishimoto, T., Mizuno, S., Masaoka, T., Naganuma, M., Liang, K.-C., Kitazawa, M., Nakashima, M., Shindo, C., Suda, W., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.038 · Cited by 205
Self-citationSasso, J. M., Ammar, R. M., Tenchov, R., Lemmel, S., Kelber, O., Grieswelle, M., & Zhou, Q. A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00127 · Cited by 204
Takewaki, D., Suda, W., Sato, W., Takayasu, L., Kumar, N., Kimura, K., Kaga, N., Mizuno, T., Miyake, S., Hattori, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011703117 · Cited by 188
Self-citationEnvironmental Influences on the Human Microbiome and Implications for Noncommunicable Disease
Ahn, J., & Hayes, R. B. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-012420-105020 · Cited by 186
Asaoka, D., Xiao, J., Takeda, T., Yanagisawa, N., Yamazaki, T., Matsubara, Y., Sugiyama, H., Endo, N., Higa, M., Kasanuki, K., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220148 · Cited by 186
Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases
Biazzo, M., & Deidda, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144119 · Cited by 183
Priorities for the next 10 years of human microbiome research
Proctor, L. M. (2019) · Nature · doi:10.1038/d41586-019-01654-0 · Cited by 178
Cai, Y.-Y., Huang, F.-Q., Lao, X., Lu, Y., Gao, X., Alolga, R. N., Yin, K., Zhou, X., Wang, Y., Liu, B., et al. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00273-4 · Cited by 175
Western Diet: Implications for Brain Function and Behavior
López-Taboada, I., González‐Pardo, H., & Conejo, N. M. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.564413 · Cited by 170
The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis
Freedman, S. N., Shahi, S. K., & Mangalam, A. K. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0588-x · Cited by 168
Matsue, M., Mori, Y., Nagase, S., Sugiyama, Y., Hirano, R., Ogai, K., Ogura, K., Kurihara, S., & Okamoto, S. (2019) · Cell Transplantation · doi:10.1177/0963689719881366 · Cited by 167
Suda, K., & Matsuda, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031172 · Cited by 167
“Several studies have shown that depressive symptoms improved in patients with irritable bowel syndrome (IBS), when treated with FMT [124,125].”
BackgroundHydrogen cross-feeders of the human gastrointestinal tract
Smith, N. W., Shorten, P. R., Altermann, E. H., Roy, N. C., & McNabb, W. C. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1546522 · Cited by 165
Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
Fukudo, S., Okumura, T., Inamori, M., Okuyama, Y., Kanazawa, M., Kamiya, T., Sato, K., Shiotani, A., Naito, Y., Fujikawa, Y., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-020-01746-z · Cited by 163
“This was reported for the first time in Japan in 2017 [223].”
BackgroundSelf-citationNew treatments and therapeutic targets for IBS and other functional bowel disorders
Simrén, M., & Tack, J. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0034-5 · Cited by 161
The gut microbiome and irritable bowel syndrome
Menees, S., & Chey, W. (2018) · F1000Research · doi:10.12688/f1000research.14592.1 · Cited by 159
“In the last open-label single-center study, Mizuno et al . enrolled 10 IBS patients (Rome III criteria) who underwent FMT via colonoscopy 65 .”
BackgroundKanai, T., Mikami, Y., & Hayashi, A. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1084-x · Cited by 159
Self-citationRecipient factors in faecal microbiota transplantation: one stool does not fit all
Danne, C., Rolhion, N., & Sokol, H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00441-5 · Cited by 154
Irritable bowel syndrome and gut microbiota
Canakis, A., Haroon, M., & Weber, H. C. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000523 · Cited by 149
Tourlousse, D. M., Narita, K., Miura, T., Sakamoto, M., Ohashi, A., Shiina, K., Matsuda, M., Miura, D., Shimamura, M., Ohyama, Y., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01048-3 · Cited by 144
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice
Moayyedi, P., Mearin, F., Azpiroz, F., Andresen, V., Barbara, G., Corsetti, M., Emmanuel, A., Hungin, A. P. S., Layer, P., Stanghellini, V., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617731968 · Cited by 135
Basso, P. J., Câmara, N. O. S., & Sales‐Campos, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01571 · Cited by 135
“This characteristic has expanded the use of FMT to treat both local and systemic illnesses associated with gut dysbiosis, such as irritable bowel syndrome (IBS) (Mizuno et al., 2017), IBD (Angelberger et al., 2013; Kunde et al., 2013) and metabolic syndrome (Vrieze et al., 2012).”
BackgroundBiodiversity of Gut Microbiota: Impact of Various Host and Environmental Factors
Anwar, H., Iftikhar, A., Muzaffar, H., Almatroudi, A., Allemailem, K. S., Navaid, S., Saleem, S., & Khurshid, M. (2021) · BioMed Research International · doi:10.1155/2021/5575245 · Cited by 130
“These short-chain fatty acids have a positive and beneficial impact on the gastrointestinal tract by having a direct impact or by having an indirect effect by further converting via other gut microbes into other shortchain fatty acids, like butyrate [58].”
BackgroundSpichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127
Inoüe, R., Ohue‐Kitano, R., Tsukahara, T., Tanaka, M., Masuda, S., Inoue, T., Yamakage, H., Kusakabe, T., Hasegawa, K., Shimatsu, A., et al. (2017) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-44 · Cited by 125
Xu, H., Cao, C., Ren, Y., Weng, S., Liu, L., Guo, C., Wang, L., Han, X., Ren, J., & Liu, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.949490 · Cited by 125
“Therefore, FMT is certainly an efficient means to modulate the host intestinal microbiota, which is considered to be a breakthrough in medical progress in recent years (18, 106).”
BackgroundIto, T., Sekizuka, T., Kishi, N., Yamashita, A., & Kuroda, M. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1491265 · Cited by 121
Delivery routes for faecal microbiota transplants: Available, anticipated and aspired
Gulati, M., Singh, S. K., Corrie, L., Kaur, I. P., & Chandwani, L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104954 · Cited by 121
Caldeira, L. D. F., Borba, H. H. L., Tonin, F. S., Wiens, A., Fernández-Llimós, F., & Pontarolo, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238910 · Cited by 117
Settanni, C. R., Ianiro, G., Bibbò, S., Cammarota, G., & Gasbarrini, A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110258 · Cited by 117
Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use
Naito, Y., Kashiwagi, K., Takagi, T., Andoh, A., & Inoüe, R. (2018) · Digestion · doi:10.1159/000481813 · Cited by 117
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 116
Circadian oscillations of microbial and functional composition in the human salivary microbiome
Takayasu, L., Suda, W., Takanashi, K., Iioka, E., Kurokawa, R., Shindo, C., Hattori, Y., Yamashita, N., Nishijima, S., Oshima, K., et al. (2017) · DNA Research · doi:10.1093/dnares/dsx001 · Cited by 115
Self-citationThe gut microbiota associated with high‐Gleason prostate cancer
Matsushita, M., Fujita, K., Motooka, D., Hatano, K., Fukae, S., Kawamura, N., Tomiyama, E., Hayashi, Y., Banno, E., Takao, T., et al. (2021) · Cancer Science · doi:10.1111/cas.14998 · Cited by 115
Déjean, G., Tamura, K., Cabrera, A., Jain, N., Pudlo, N. A., Pereira, G. V., Viborg, A. H., Petegem, F. V., Martens, E. C., & Brumer, H. (2020) · mBio · doi:10.1128/mbio.00095-20 · Cited by 112
Casagrande, S., Sopetto, G. B., Bertalot, G., Bortolotti, R., Racanelli, V., Caffo, O., Giometto, B., Berti, A., & Veccia, A. (2024) · Cancers · doi:10.3390/cancers16071440 · Cited by 109
Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India
Silva, M. C. A., Kashani, A., Hansen, T. H., Pinna, N. K., Anjana, R. M., Dutta, A., Saxena, S., Støy, J., Kampmann, U., Nielsen, T., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00856-4 · Cited by 108
Long-read metagenomic exploration of extrachromosomal mobile genetic elements in the human gut
Suzuki, Y., Nishijima, S., Furuta, Y., Yoshimura, J., Suda, W., Oshima, K., Hattori, M., & Morishita, S. (2019) · Microbiome · doi:10.1186/s40168-019-0737-z · Cited by 107
Self-citationCharacteristics of the Gut Bacterial Composition in People of Different Nationalities and Religions
Syromyatnikov, M., Nesterova, E. Y., Gladkikh, M. I., Dmitrievna, S. Y., Vladimirovna, G. M., & Popov, V. N. (2022) · Microorganisms · doi:10.3390/microorganisms10091866 · Cited by 107
Identification of trypsin-degrading commensals in the large intestine
Li, Y., Watanabe, E., Kawashima, Y., Plichta, D. R., Wang, Z., Ujike, M., Ang, Q. Y., Wu, R., Furuichi, M., Takeshita, K., et al. (2022) · Nature · doi:10.1038/s41586-022-05181-3 · Cited by 106
Self-citationEdwinson, A. L., Yang, L., Peters, S., Hanning, N., Jeraldo, P., Jagtap, P., Simpson, J. B., Yang, T.-Y., Kumar, P., Mehta, S., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01103-1 · Cited by 105
Hosomi, K., Ohno, H., Murakami, H., Natsume‐Kitatani, Y., Tanisawa, K., Hirata, S., Suzuki, H., Nagatake, T., Nishino, T., Mizuguchi, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04511-0 · Cited by 103
Suzuki, A., Ito, M., Hamaguchi, T., Mori, H., Takeda, Y., Baba, R., Watanabe, T., Kurokawa, K., Asakawa, S., Hirayama, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208313 · Cited by 98
Lindstad, L. J., Lo, G., Leivers, S., Lu, Z., Michalak, L., Pereira, G. V., Røhr, Å. K., Martens, E. C., McKee, L. S., Louis, P., et al. (2021) · mBio · doi:10.1128/mbio.03628-20 · Cited by 98
Hirayama, M., Nishiwaki, H., Hamaguchi, T., Ito, M., Ueyama, J., Maeda, T., Kashihara, K., Tsuboi, Y., & Ohno, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260451 · Cited by 97
Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?
Martín‐Núñez, G. M., Cornejo-Pareja, I. M., Clemente‐Postigo, M., & Tinahones, F. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639856 · Cited by 96
Gut microbiota‐immune‐brain interactions in chemotherapy‐associated behavioral comorbidities
Jordan, K. R., Loman, B. R., Bailey, M. T., & Pyter, L. M. (2018) · Cancer · doi:10.1002/cncr.31584 · Cited by 94
Human Gut Microbiome Response Induced by Fermented Dairy Product Intake in Healthy Volunteers
Игоревна, В. О., Klimenko, N. S., Berezhnaya, Y., Tyakht, A., Nesterova, P., Popenko, A., & Alexeev, D. G. (2019) · Nutrients · doi:10.3390/nu11030547 · Cited by 93
Diverse events have transferred genes for edible seaweed digestion from marine to human gut bacteria
Pudlo, N. A., Pereira, G. V., Parnami, J., Cid, M., Markert, S., Tingley, J. P., Unfried, F., Ali, A. Y., Varghese, N. J., Kim, K. S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.001 · Cited by 93
Mechanistic insights into consumption of the food additive xanthan gum by the human gut microbiota
Ostrowski, M. P., Rosa, S. L. L., Kunath, B. J., Robertson, A., Pereira, G. V., Hagen, L. H., Varghese, N. J., Qiu, L., Yao, T., Flint, G., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01093-0 · Cited by 93
Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome
Harris, L. A., & Baffy, N. J. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1383819 · Cited by 92
“03) and efficacy of FMT was dependent on increased concentrations of bifidobacteria in the donor stool [123].”
BackgroundFecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta‐analysis
Myneedu, K., Deoker, A., Schmulson, M. J., & Bashashati, M. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619866990 · Cited by 91
Nishida, A., Imaeda, H., Ohno, M., Inatomi, O., Bamba, S., Sugimoto, M., & Andoh, A. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1271-4 · Cited by 91
Bifidobacterium: a probiotic for the prevention and treatment of depression
Li, J., Wang, J., Wang, M., Zheng, L., Cen, Q., Wang, F., Li, Z., Pang, R., & Zhang, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1174800 · Cited by 90
“In addition, FMT can improve stool patterns and depressive symptoms by increasing the diversity of gut microbiota in IBS patients (Mizuno et al., 2017).”
BackgroundHuang, H. L., Chen, H. T., Luo, Q. L., Xu, H. M., He, J., Li, Y. Q., Zhou, Y. L., Yao, F., Nie, Y. Q., & Zhou, Y. J. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12756 · Cited by 89
Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease
Imai, T., Inoüe, R., Kawada, Y., Morita, Y., Inatomi, O., Nishida, A., Bamba, S., Kawahara, M., & Andoh, A. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1530-7 · Cited by 88
Fukui, H., Nishida, A., Matsuda, S., Kira, F., Watanabe, S., Kuriyama, M., Kawakami, K., Aikawa, Y., Oda, N., Arai, K., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082403 · Cited by 88
Akiyama, S., Nishijima, S., Kojima, Y., Kimura, M., Ohsugi, M., Ueki, K., Mizokami, M., Hattori, M., Tsuchiya, K., Uemura, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54797-8 · Cited by 87
Self-citationCruz-Aguliar, R. M., Wantia, N., Clavel, T., Vehreschild, M. J. G. T., Buch, T., Bajbouj, M., Haller, D., Busch, D. H., Schmid, R. M., & Stein‐Thoeringer, C. K. (2018) · Digestion · doi:10.1159/000494252 · Cited by 85
Meta-analysis of shotgun sequencing of gut microbiota in Parkinson’s disease
Nishiwaki, H., Ueyama, J., Ito, M., Hamaguchi, T., Takimoto, K., Maeda, T., Kashihara, K., Tsuboi, Y., Mori, H., Kurokawa, K., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00724-z · Cited by 85
NIR light-responsive bacteria with live bio-glue coatings for precise colonization in the gut
Cui, M., Sun, T., Li, S., Pan, H., Liu, J., Zhang, X., Li, L., Li, S., Wei, C., Yu, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109690 · Cited by 81
Katoh, T., Ojima, M. N., Sakanaka, M., Ashida, H., Gotoh, A., & Katayama, T. (2020) · Microorganisms · doi:10.3390/microorganisms8040481 · Cited by 80
Exploring the universal healthy human gut microbiota around the World
Piquer-Esteban, S., Ruiz‐Ruiz, S., Arnau, V., Díaz-Villanueva, W., & Moyá, A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.12.035 · Cited by 80
Human gut microbiome, diet, and mental disorders
Borrego-Ruiz, A., & Borrego, J. J. (2024) · International Microbiology · doi:10.1007/s10123-024-00518-6 · Cited by 79
Two Blautia Species Associated with Visceral Fat Accumulation: A One-Year Longitudinal Study
Ozato, N., Yamaguchi, T. F., Mori, K., Katashima, M., Kumagai, M., Murashita, K., Katsuragi, Y., Tamada, Y., Kakuta, M., Imoto, S., et al. (2022) · Biology · doi:10.3390/biology11020318 · Cited by 77
Mocanu, V., Rajaruban, S., Dang, J. T., Kung, J. Y. C., Deehan, E. C., & Madsen, K. L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050959 · Cited by 77
Kato, K., Ishida, S., Tanaka, M., Mitsuyama, E., Xiao, J., & Odamaki, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206189 · Cited by 75
Hamajima, H., Matsunaga, H., Fujikawa, A., Sato, T., Mitsutake, S., Yanagita, T., Nagao, K., Nakayama, J., & Kitagaki, H. (2016) · SpringerPlus · doi:10.1186/s40064-016-2950-6 · Cited by 75
Ishida, S., Kato, K., Tanaka, M., Odamaki, T., Kubo, R., Mitsuyama, E., Xiao, J., Yamaguchi, R., Uematsu, S., Imoto, S., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01416-z · Cited by 74
Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives
Zheng, L., Ji, Y.-Y., Wen, X., & Duan, S.-L. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i23.2546 · Cited by 74
Park, J., Kato, K., Murakami, H., Hosomi, K., Tanisawa, K., Nakagata, T., Ohno, H., Konishi, K., Kawashima, H., Chen, Y.-A., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02215-0 · Cited by 72
Firmicutes in Gut Microbiota Correlate with Blood Testosterone Levels in Elderly Men
Matsushita, M., Fujita, K., Motooka, D., Hatano, K., Hata, J., Nishimoto, M., Banno, E., Takezawa, K., Fukuhara, S., Kiuchi, H., et al. (2022) · The World Journal of Men s Health · doi:10.5534/wjmh.210190 · Cited by 72
Exploring the Relationship between the Gut Microbiota and Ageing: A Possible Age Modulator
Salazar, J., Durán, P., Díaz, M. P., Chacín, M., Santeliz, R., Mengual, E., Gutiérrez, E., León, X., Díaz, A., Bernal, M., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20105845 · Cited by 71
Boronat, A., Rodríguez-Morató, J., Serreli, G., Fitó, M., Tyndale, R. F., Deiana, M., & de la Torre, R. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab085 · Cited by 71
Ojima, M., Shimizu, K., Motooka, D., Ishihara, T., Nakamura, S., Shintani, A., Ogura, H., Iida, T., Yoshiya, K., & Shimazu, T. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07000-7 · Cited by 69
Hosoda, S., Nishijima, S., Fukunaga, T., Hattori, M., & Hamada, M. (2020) · Microbiome · doi:10.1186/s40168-020-00864-3 · Cited by 68
Self-citationThe Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
Fujita, K., Matsushita, M., Velasco, M. A. D., Hatano, K., Minami, T., Nonomura, N., & Uemura, H. (2023) · Cancers · doi:10.3390/cancers15051375 · Cited by 67
Metadata
- Authors
- Mizuno, S., Masaoka, T., Naganuma, M., Kishimoto, T., Kitazawa, M., Kurokawa, S., Nakashima, M., Takeshita, K., Suda, W., Mimura, M., Hattori, M., & Kanai, T.
- Affiliations
- Keio University (JP)
- Waseda University (JP)
- ORCID
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 96
- Issue
- 1
- Pages
- 29-38
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- PMC
- PMC5637308
- OpenAlex
- W2657252452
- Cited by
- 395
- References
- 37
- Citations by year
- 2026: 7 · 2025: 28 · 2024: 34 · 2023: 52 · 2022: 76 · 2021: 46 · 2020: 45 · 2019: 41 · 2018: 38 · 2017: 19
- FWCI
- 41.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Digestion (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tokyo Medical and Dental University
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- fecal microbiota transplantation, irritable bowel syndrome, Bifidobacterium, donor selection, predictors of treatment response, gut dysbiosis, stool consistency, psychological state, Hamilton Depression Rating Scale, gut microbiota diversity
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Adult, Bifidobacterium, Colonoscopy, Feces, Female, Humans, Intestines, Japan, Male, Middle Aged, Treatment Outcome, Living Donors, Irritable Bowel Syndrome, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.